Pragmatic approaches to determine the exposures of drug metabolites in preclinical and clinical subjects in the MIST evaluation of the clinical development phase.
about
Pragmatic approaches to determine the exposures of drug metabolites in preclinical and clinical subjects in the MIST evaluation of the clinical development phase.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Pragmatic approaches to determ ...... he clinical development phase.
@en
Pragmatic approaches to determ ...... he clinical development phase.
@nl
type
label
Pragmatic approaches to determ ...... he clinical development phase.
@en
Pragmatic approaches to determ ...... he clinical development phase.
@nl
prefLabel
Pragmatic approaches to determ ...... he clinical development phase.
@en
Pragmatic approaches to determ ...... he clinical development phase.
@nl
P2093
P356
P1476
Pragmatic approaches to determ ...... he clinical development phase.
@en
P2093
Anna Sandholm
Antti Kautiainen
Asa Brunnström
Göran Eklund
Johanna Haglund
Suzanne L Iverson
P304
P356
10.1021/TX400449Z
P577
2014-03-24T00:00:00Z